Navesta opens LKR1.4bn sterile drug plant in Sri Lanka

By Gareth Macdonald contact

- Last updated on GMT


Related tags: Sri lanka

Navesta Pharmaceuticals had opened a sterile drug manufacturing facility in Horana, Sri Lanka.

The plant – which is compliant with European Union Good Manufacturing Practices (EU-GMP) and Pharmaceutical Inspection Co-Operation Scheme (PIC/S) standards - will make penicillin-based antibiotics for the local market.

According to Navesta the facility will initially manufacture 50 million vials per year. The firm said it plans to increase production capacity three-fold in the next few years.

Company chairman Sanjaya Jayaratne said: “Navesta’s ultimate aim is to provide a reliable, vertically integrated local supply chain which will provide accessibility of high quality pharmaceuticals for our citizens.”

In 2015​, the Sri Lankan Government introduced laws designed to encourage drug production in the country.

Navesta said the regulations had prompted it to invest LKR1.4bn ($9.1m) in construction and development of the facility

Related news

Related products

show more

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Related suppliers

Follow us


View more